GC Medical Science Corporation (KOSDAQ:142280)
South Korea · Delayed Price · Currency is KRW 3,105.00
+5.00 (0.16%)
At close: Sep 11, 2026
GC Medical Science Market Cap
GC Medical Science has a market cap or net worth of 74.41 billion as of September 11, 2026. Its market cap has decreased by -15.50% in one year.
Market Cap
74.41B
Enterprise Value
91.46B
Revenue
102.16B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,105.00
ChartMarket Cap Chart
Since December 17, 2014, GC Medical Science's market cap has decreased from 98.95B to 74.41B, a decrease of -24.80%. That is a compound annual growth rate of -2.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 74.41B | -14.55% |
| Dec 30, 2025 | 87.08B | 12.05% |
| Dec 30, 2024 | 77.71B | -22.72% |
| Dec 28, 2023 | 100.56B | -17.47% |
| Dec 29, 2022 | 121.86B | -20.00% |
| Dec 30, 2021 | 152.32B | -53.95% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Dx & Vx | 234.26B |
| 3billion | 136.84B |
| GENINUS | 71.10B |
| Cytogen | 70.65B |
| Inventera | 68.98B |
| Protia | 67.62B |
| HLB Panagene | 53.45B |
| Seoulin Bioscience | 36.62B |